Roche: Roche to present latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association 2025 conference
Roche announced that it will present new data at the Muscular Dystrophy Association (MDA) conference, 16─19 March, 2025, in Dallas, Texas, from its neuromuscular portfolio, including 12 oral and poster presentations.
Read full article »
Roche is a Switzerland-based biotechnology company that discovers, develops, and provides diagnostic and pharmaceutical products and services for the healthcare sector.
Read more